Yildiz Mehmet, Wade Spencer R, Henry Timothy D
The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital, Cincinnati, OH, United States of America.
Department of Internal Medicine at The Christ Hospital, Cincinnati, OH, United States of America.
Am Heart J Plus. 2021 Nov;11:100044. doi: 10.1016/j.ahjo.2021.100044. Epub 2021 Aug 25.
Tremendous progress has been made in the treatment of ST-segment elevation myocardial infarction (STEMI), the most severe and time-sensitive acute coronary syndrome. Primary percutaneous coronary intervention (PCI) is the preferred method of reperfusion, which has stimulated the development of regional STEMI systems of care with standardized protocols designed to optimize care. However, challenges remain for patients with cardiogenic shock, out-of-hospital cardiac arrest, an expected delay to reperfusion (>120 min), in-hospital STEMI, and more recently, those with Covid-19 infection. Ultimately, the goal is to provide timely reperfusion with primary PCI coupled with the optimal antiplatelet and anticoagulant therapies. We review the challenges and provide insights into the remaining knowledge gaps for contemporary STEMI care.
在ST段抬高型心肌梗死(STEMI)的治疗方面已经取得了巨大进展,STEMI是最严重且对时间敏感的急性冠状动脉综合征。直接经皮冠状动脉介入治疗(PCI)是首选的再灌注方法,这推动了区域STEMI护理系统的发展,该系统采用标准化方案以优化护理。然而,对于心源性休克、院外心脏骤停、预期再灌注延迟(>120分钟)、院内STEMI以及最近感染新冠病毒的患者来说,挑战依然存在。最终目标是通过直接PCI及时进行再灌注,并结合最佳的抗血小板和抗凝治疗。我们回顾了这些挑战,并对当代STEMI护理中尚存的知识空白提供见解。